58 Week Open-Label Trial of Tavapadon in PD (TemPo-4 Trial)

Clinical Trial Grant

Duke Scholars

Principal Investigator Jeffrey W Cooney Neurology, Movement Disorders

Administered By

Neurology, Movement Disorders

Awarded By

Cerevel Therapeutics

Start Date

October 13, 2020

End Date

December 31, 2024

Administered By

Neurology, Movement Disorders

Awarded By

Cerevel Therapeutics

Start Date

October 13, 2020

End Date

December 31, 2024